evolcSign inStart free
Menu

Lymviva

Developing therapeutics for fibrotic diseases

London, United KingdomFounded 2024lymviva.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-09

About Lymviva

Lymviva is developing new approaches to treating fibrotic disease using biology-led, AI-enabled science.

Product: Therapeutics for fibrotic diseases under development.

Jobs at Lymviva

No open positions listed right now.

More biotech & pharma companies

  • Macomics

    Macrophage-directed drugs that clear large disease protein complexes, first targeting IgA nephropathy patients
    Edinburgh, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Manteisbio

    Scientific and drug-development consulting for biotech, pharma, virtual companies, investors and public organizations
    London, United KingdomBiotech & pharmaFounded 2025
    Young companyNew on Evolc

  • Manx Healthcare

    UK pharmaceutical manufacturer and distributor supplying generic and over-the-counter medicines to healthcare customers
    Warwick, United KingdomBiotech & pharmaFounded 1994
    New on Evolc

  • Matheus Engineering

    Contract process engineering research and scale-up services for pharmaceutical and chemical manufacturers
    Sandwich, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Matrix Science

    Proteomics software for researchers, core labs, industry and educators analyzing mass spectrometry data
    London, United KingdomBiotech & pharmaFounded 1998
    New on Evolc

  • Maxion Therapeutics

    Engineered protein therapeutics for ion channel- and GPCR-driven diseases
    London, United KingdomBiotech & pharmaFounded 2020
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.